Gesellschaftsrecht / M&A

Immobilien

IP / IT

Arbeitsrecht und Vergütung für Führungskräfte

Steuern

Wettbewerb

Solabia Group

Homburger News

Homburger advises Solabia Développement S.A.S. on its acquisition of the Mibelle Biochemistry Business from Persán

On February 19, 2026, Solabia Group announced that it has entered into an agreement to acquire the Mibelle Biochemistry Business from Persán, a multinational European market leader in home and personal care. The Mibelle Biochemistry Business, part of the Mibelle Group, is a Swiss innovator specializing in the development and production of high‑performance active ingredients for the cosmetics, nutraceutical and food industries.
The transaction is expected to close in the first half of 2026, subject to the satisfaction of customary closing conditions.
The Homburger team was led by Daniel Hasler (Corporate / M&amp;A) and included Carlo Sulser, Cédric Berger, Anina Preusker and Viviane Egli (all Corporate / M&amp;A), Olivier Bühlmann (Real Estate), Gregor Bühler, Joel Fink and Berem Brun (all IP / IT), Angela Casey (Employment and Executive Compensation), Reto Heuberger and Juliette Buob (both Tax) as well as Richard Stäuber and Nicolas Stocker (both Competition).

Healthcare / Life Sciences

Homburger advised the shareholders of Clariness AG on the sale of 100% of their shares to SubjectWell, Inc.

On January 27, 2026, SubjectWell, Inc. announced the acquisition of Swiss-based Clariness AG and the merger of Clariness and SubjectWell to form one of the largest global, full-service patient recruitment platforms, combining global scale, scientific rigor, and patient-first design to transform clinical trial access and execution worldwide.
Homburger acted as transaction counsel to the selling shareholders. The Homburger team comprised Andreas Müller, Carlo Sulser, Marco Rostetter, Anina Preusker, and Viviane Egli (all M&amp;A), Reto Heuberger and Philippe Weber (both Tax), Luca Dal Molin and Joel Fink (both IP / IT and Healthcare / Life Sciences), and Richard Stäuber, Allegra Arnold, and Timothy Porter (all Competition).

Kapitalmarkt

Finanzmarktrecht

Homburger advises EQT on the sale of an additional 10% in Galderma to L’Oréal, reinforcing L’Oréal’s strategic investment in Galderma

On December 8, 2025, EQT announced the sale of an additional 10% stake in Galderma Group AG (SIX: GALD) by a consortium led by EQT, which includes Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as sellers) to L’Oréal S.A. for an undisclosed amount. Following the transaction, which is subject to customary regulatory approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024.
The EQT-led consortium and L’Oréal agreed to customary provisions for an investment of this type. The previously concluded shareholder undertaking between SSCO and L’Oréal will be dissolved effective upon completion of the transaction.
In connection with the increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal.
Homburger acted as transaction counsel to EQT. The team was led by Frank Gerhard and Margrit Marti, and comprised Carlo Sulser, Estelle Piccard, Jannis Zafeirakos and Viviane Egli (all Corporate / M&amp;A, Capital Markets), Stefan Oesterhelt and Laetitia Fracheboud (both Tax), Richard Stäuber and Giulia Meier (both Competition) as well as Micha Fankhauser (Financial Market Regulation).

Viviane
Egli

Homburger advises Solabia Développement S.A.S. on its acquisition of the Mibelle Biochemistry Business from Persán

Homburger advised the shareholders of Clariness AG on the sale of 100% of their shares to SubjectWell, Inc.

Homburger advises EQT on the sale of an additional 10% in Galderma to L’Oréal, reinforcing L’Oréal’s strategic investment in Galderma

Digitale Generalversammlungen und Verwaltungsratssitzungen: erste Erfahrungen und Empfehlungen

Join the Team

Viviane Egli

Karriere

Sprachen

Zulassung

Teams

VivianeEgli

Homburger advises Solabia Développement S.A.S. on its acquisition of the Mibelle Biochemistry Business from Persán

Homburger advised the shareholders of Clariness AG on the sale of 100% of their shares to SubjectWell, Inc.

Homburger advises EQT on the sale of an additional 10% in Galderma to L’Oréal, reinforcing L’Oréal’s strategic investment in Galderma

Digitale Generalversammlungen und Verwaltungsratssitzungen: erste Erfahrungen und Empfehlungen

Join the Team

Viviane Egli

Karriere

Sprachen

Zulassung

Teams

Viviane
Egli